Samsara BioCapital GP, LLC

MLYS

Samsara BioCapital GP, LLC serves as an insider at Mineralys Therapeutics, Inc. (MLYS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$16.86M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$16.86M

Companies Traded

MLYS, NGNE

Active Period

Feb 2024 – Mar 2025

3 total trades

Most Recent

Buy MLYS

Mar 17, 2025 · $8.10M

Samsara BioCapital GP, LLC's Insider Trading at Mineralys Therapeutics, Inc. (MLYS)

Buys

2 · $15.60M

Sells

0 · $0.00

Total Shares Bought

1,155,555

Total Shares Sold

MLYS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 17, 2025↗	Buy	600,000	$13.50	$8.10M	5,674,920
Feb 14, 2024↗	Buy	555,555	$13.50	$7.50M	5,074,920

Samsara BioCapital GP, LLC's Insider Trading at Neurogene Inc. (NGNE)

Buys

1 · $1.26M

Sells

0 · $0.00

Total Shares Bought

48,770

Total Shares Sold

NGNE Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 27, 2024↗	Buy	48,770	$25.83	$1.26M	1,717,130

Related Insiders

David Malcom Rodman

officer: Chief Medical Officer

MLYSSell · Mar 17, 2026

Stuart Cobb

officer: Chief Scientific Officer

NGNESell · Mar 17, 2026

Christine Mikail Cvijic

officer: President and CFO

NGNESell · Mar 17, 2026

David Malcom Rodman

Chief Medical Officer

MLYSSell · Feb 17, 2026

Jon Congleton

director, officer: Chief Executive Officer

MLYSSell · Jan 13, 2026

Adam Scott Levy

officer: CFO and Secretary

MLYSSell · Jan 13, 2026

Brian Taylor Slingsby

Director

MLYSSell · Nov 21, 2025

Daphne Karydas

Director

MLYSSell · Nov 13, 2025

Explore More Insider Trading Data

MLYS Insider Trading Activity

View all insider trades at Mineralys Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity